GDTC (CytoMed) Pangali Forward P/E
The forward P/E ratio of CytoMed Therapeutics (GDTC) exhibits volatility, with the metric currently standing at 0.00. This price action is driven by early-stage immunotherapy trials and capital expenditures. Growth is supported by the optimization of cryogenic logistics to preserve margins and a strategic alliance with hospitals for the treatment of intestinal and liver tumors using the T-cell method.
Ringkesan rincian data analitis CytoMed (GDTC)
- rega saiki lan proyeksi nilai saham:
- indikator valuasi pasar bisnis:
- informasi kapitalisasi buku:
- indikator beban kredit lan likuiditas emiten:
Total Utang marang Modal CytoMed Therapeutics|GDTC - Kewajiban jangka dawa marang modal|Utang jangka cendhak marang modal CytoMed Therapeutics|GDTC - Gunggung utang perusahaan|Utang marang nilai buku CytoMed Therapeutics Ltd|GDTC - Utang jangka dawa|Kewajiban jangka cendhak perusahaan CytoMed Therapeutics|Likuiditas cepet w2.cytomed.sg
- rincian asil keuangan lan kelipatan valuasi:
GDTC - Penghasilan resik perusahaan|Bathi sing dikarepake CytoMed Therapeutics|GDTC - Koefisien rega marang bathi|Pangali Forward P/E CytoMed Therapeutics|GDTC - Rega marang bathi kanthi panyesuaian wutah|Pangali EV/EBITDA CytoMed Therapeutics Ltd|GDTC - Bathi operasional sadurunge amortisasi|Bathi resik saben saham sajrone 12 wulan pungkasan CytoMed Therapeutics|GDTC - Bathi saben saham sajroning taun lumaku|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan w2.cytomed.sg|GDTC - Wutah bathi resik saben siji saham kanggo taun lumaku|Prakiraan wutah bathi kanggo taun ngarep CytoMed Therapeutics
- indikator volume dodolan lan pendapatan:
Analisis fundamental perusahaan:CytoMed Therapeutics Limited GDTC
Fundamental valuation via forward P/E minimizes risks by comparing the current share price of CytoMed Therapeutics (GDTC) with projected earnings from the implementation of donor CAR-T therapies in oncology centers. Analyzing changes in the company's expected P/E allows for a determination of the extent to which the market has priced in future insurance payouts, assessing the effectiveness of business capitalization through the ratio of market value to expected earnings.
Pesaing CytoMed Therapeutics (GDTC)
Prakiraan rega marang bathi ONC (BeiGene)|HALO (Halozyme Therapeutics, Inc.) - Pangali mangsa ngarep rega marang bathi|Pangali Forward P/E RVMD (RevMed)|AAPG - Prakiraan rega marang bathi|CGON: Prakiraan rega marang bathi|URGN - Pangali Forward P/E|Bicara Therapeutics (BCAX) - Rega marang bathi mangsa ngarep|Personalis Inc - Pangali mangsa ngarep rega marang bathi|ERAS (Erasca Corp) - Pangali Forward P/E|Rasio prakiraan rega marang bathi Delcath Corp DCTH|Pangali Forward P/E YMAB|Prakiraan rega marang bathi aurabiosciences.com AURA|Candel Therapeutics, Inc. - Prakiraan rega marang bathi|Accuray Inc (ARAY) - Rasio prakiraan rega marang bathi|SLS: Prakiraan rega marang bathi|Actuate Therapeutics Inc - Rasio kapitalisasi marang bathi mangsa ngarep|Citius Oncology, Inc. (CTOR) - Rega marang bathi mangsa ngarep|Rasio prakiraan rega marang bathi TuHURA Biosciences (HURA)|Rega marang bathi mangsa ngarep Protara Therapeutics, Inc.|Prakiraan rega marang bathi Fate Therapeutics Inc (FATE)|Pangali Forward P/E WHWK|TCRX - Rasio prakiraan rega marang bathi|Pangali Forward P/E CSBR (Champions Oncology, Inc.)|XBIT: Rasio rega marang bathi mangsa ngarep|CVM: Prakiraan rega marang bathi|Pangali mangsa ngarep rega marang bathi OSTX (OS Therapies Inc.)|RADX (Radiopharm Theranostics Limited) - Prakiraan rega marang bathi|ARTV: Rasio kapitalisasi marang bathi mangsa ngarep|ANL (Adlai Nortye Ltd) - Pangali Forward P/E|VERU: Pangali mangsa ngarep rega marang bathi|Pangali Forward P/E TPST|XLO - Rasio prakiraan rega marang bathi|Rega marang bathi mangsa ngarep Renovaro RENB|Pangali mangsa ngarep rega marang bathi MURA|Kairos Pharma Inc - Pangali Forward P/E|OKUR - Pangali Forward P/E|curis.com (CRIS) - Rega marang bathi mangsa ngarep|Rasio rega marang bathi sing dikarepake APLM (Apollomics)|THAR (Tharimmune Corp) - Pangali Forward P/E|Rasio prakiraan rega marang bathi Advanced Biomed Corp ADVB|Prakiraan rega marang bathi GNPX (Genprex, Inc.)|Pangali Forward P/E calidibio.com (CLDI)|Sunshine Biopharma, Inc. - Prakiraan rega marang bathi|Rasio kapitalisasi marang bathi mangsa ngarep XBIO (Xenetic Biosciences Inc.)|Salarius - Pangali Forward P/E|Kapitalisasi marang proyeksi bathi Kitov Pharma PPBT|AONC: Pangali Forward P/E|Prakiraan rega marang bathi beigene.com|Rega marang bathi mangsa ngarep Checkpoint Therapeutics, Inc.|elevationoncology.com (ELEV) - Kapitalisasi marang proyeksi bathi|Pangali Forward P/E ICAD|ikenaoncology.com (IKNA) - Pangali forward rega marang bathi|Pangali Forward P/E NTBL (Notable Labs, Ltd.)|VIRX: Rasio rega marang bathi mangsa ngarep|MOR: Prakiraan rega marang bathi|NAYA Biosciences Inc - Rasio kapitalisasi marang bathi mangsa ngarep|AAPGV: Pangali Forward P/E
